Cited 0 times in Scipus Cited Count

P2.12-01: Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study

DC Field Value Language
dc.contributor.authorKang, J-
dc.contributor.authorLee, KH-
dc.contributor.authorKim, D-
dc.contributor.authorKim, S-
dc.contributor.authorKim, HR-
dc.contributor.authorKim, J-
dc.contributor.authorChoi, JH-
dc.contributor.authorAn, HJ-
dc.contributor.authorKim, J-
dc.contributor.authorJang, JS-
dc.contributor.authorKim, B-
dc.contributor.authorKim, HT-
dc.date.accessioned2019-12-10T06:53:47Z-
dc.date.available2019-12-10T06:53:47Z-
dc.date.issued2018-
dc.identifier.issn1556-0864-
dc.identifier.urihttp://repository.ajou.ac.kr/handle/201003/17817-
dc.formatapplication/pdf-
dc.language.isoen-
dc.titleP2.12-01: Efficacy of Belotecan as Second-Line Treatment for Recurrent Small Cell Lung Cancer: A Phase IIb Randomized Multicenter Study-
dc.typeArticle-
dc.contributor.affiliatedAuthor최, 진혁-
dc.type.localJournal Papers-
dc.identifier.doi10.1016/j.jtho.2018.08.1377-
dc.citation.titleJournal of thoracic oncology-
dc.citation.volume13-
dc.citation.number10S-
dc.citation.date2018-
dc.citation.startPageS790-
dc.citation.endPageS791-
dc.identifier.bibliographicCitationJournal of thoracic oncology, 13(10S). : S790-S791, 2018-
dc.embargo.liftdate9999-12-31-
dc.embargo.terms9999-12-31-
dc.identifier.eissn1556-1380-
dc.relation.journalidJ015560864-
Appears in Collections:
Journal Papers > School of Medicine / Graduate School of Medicine > Hematology-Oncology
Files in This Item:
There are no files associated with this item.

qrcode

해당 아이템을 이메일로 공유하기 원하시면 인증을 거치시기 바랍니다.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse